These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23739770)

  • 1. Effects of a Rho kinase inhibitor on the sequential expression of ICAM-1, HIF-1α, Bcl-2 and caspase-3 in the retina of rats with oxygen-induced retinopathy.
    Wang H; Chen X
    Int J Mol Med; 2013 Aug; 32(2):457-63. PubMed ID: 23739770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasudil, a Rho-associated protein kinase inhibitor, attenuates retinal ischemia and reperfusion injury in rats.
    Song H; Gao D
    Int J Mol Med; 2011 Aug; 28(2):193-8. PubMed ID: 21455561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
    Saito Y; Geisen P; Uppal A; Hartnett ME
    Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice.
    Pan X; Lv Y
    Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Rho-kinase inhibition using fasudil in mice with oxygen-induced retinopathy.
    Brockmann C; Corkhill C; Jaroslawska E; Dege S; Brockmann T; Kociok N; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1699-1708. PubMed ID: 31152312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Liu N; Chen L; Cai N
    Int J Clin Exp Pathol; 2015; 8(5):4990-8. PubMed ID: 26191192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α.
    Matoba K; Kawanami D; Okada R; Tsukamoto M; Kinoshita J; Ito T; Ishizawa S; Kanazawa Y; Yokota T; Murai N; Matsufuji S; Takahashi-Fujigasaki J; Utsunomiya K
    Kidney Int; 2013 Sep; 84(3):545-54. PubMed ID: 23615507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of fasudil hydrochloride post-conditioning on acute myocardial ischemia/reperfusion injury in rats.
    Jiang ZH; Zhang TT; Zhang JF
    Cardiol J; 2013; 20(2):197-202. PubMed ID: 23558879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
    Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of Samul-tang on retinal neovascularization in oxygen-induced retinopathy.
    Lee YM; Kim CS; Jo K; Sohn EJ; Kim JS; Kim J
    BMC Complement Altern Med; 2015 Aug; 15():271. PubMed ID: 26264147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
    Fang X; Ueno M; Yamashita T; Ikuno Y
    Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
    Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H
    Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy in the rat 50/10 model.
    Trichonas G; Lee TJ; Hoppe G; Au J; Sears JE
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4919-26. PubMed ID: 23761085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of epidermal growth factor-like domain 7 regulated by oxygen tension via hypoxia inducible factor (HIF)-1α activity.
    Liu YS; Huang ZW; Qin AQ; Huang Y; Giordano F; Lu QH; Jiang WD
    Postgrad Med; 2015 Mar; 127(2):144-9. PubMed ID: 25539718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of retinal neovascularization in a rat model of oxygen fluctuations-induced retinopathy].
    Liu X; Wang W; Wang AR; Ning Q; Luo XP
    Zhonghua Er Ke Za Zhi; 2007 Jan; 45(1):7-13. PubMed ID: 17349140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
    Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
    J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia.
    Kim YH; Chung IY; Choi MY; Kim YS; Lee JH; Park CH; Kang SS; Roh GS; Choi WS; Yoo JM; Cho GJ
    Neurobiol Dis; 2007 Jun; 26(3):569-76. PubMed ID: 17434742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diacylglycerol kinase (DGK) inhibitor II (R59949) could suppress retinal neovascularization and protect retinal astrocytes in an oxygen-induced retinopathy model.
    Yang L; Xu Y; Li W; Yang B; Yu S; Zhou H; Yang C; Xu F; Wang J; Gao Y; Huang Y; Lu L; Liang X
    J Mol Neurosci; 2015 May; 56(1):78-88. PubMed ID: 25451596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of interfering RNA targeting HIF-1alpha and VEGF on retinal neovascularization in the mouse].
    Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
    Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):921-8. PubMed ID: 19176122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.